Tirabrutinib hydrochloride is a potent, highly selective, and irreversible oral BTK inhibitor. Tirabrutinib hydrochloride irreversibly covalently binds to Bruton tyrosine kinase (BTK) in B cells and exhibits potent in vitro cytotoxicity against many types of B cell malignancies, as well as in vivo antitumor activity in mouse models [1].
Molekulargewicht:
490.94
Reinheit:
98.90%
CAS Nummer:
[1439901-97-9]
Formel:
C25H23ClN6O3
Target-Kategorie:
Apoptosis|||BTK
T12311
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten